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ABSTRACT
Spraying estradiol-1713, progesterone or norethisterone intranasally in adult male rhesus mon-
keys (7.5-11 kg BW) at a daily dose of 30 pg/day for a period of 60 days resulted in a decrease of
testicular size, arrest of spermatogenesis and a significant reduction in serum levels of testosterone.
No changes were observed in the solvent-treated controls.
INTRODUCTION
Estrogens (Balze et al., 1954; Fnck et al.,
1976) or progestins (Ueller et al., 1958; Johans-
son and Nygren, 1973) administered by paren-
teral routes are known to suppress spermato-
genesis and also to reduce levels of testosterone
in the circulation. The dose of steroids required
to be administered by the oral or systemic
routes to achieve such effects is quite large.
Studies carried out in our laboratories have
shown that ovarian functions can be impaired
by administering extremely small quantities of
progestins by the intranasal route to rhesus
monkeys (Anand Kumar et al., 1977). In view
of these findings it was of interest to determine
if testicular functions are also impaired in adult
rhesus monkeys following intranasal adminis-
tration of estradiol-1 7j3 (E), progesterone (P),
or norethisterone (NET) at a daily dose of 30
pg of each steroid given over a period of 60
days.
Animals
MATERIALS AND METHODS
Eleven adult male rhesus monkeys, each weighing
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between 7.5-11.0 kg were used. The animals were
individually caged and fed with pelleted diet (Hin-
dustan Lever) supplemented with fresh fruits, vege-
tables and freely available water. The animals were
maintained in well aerated rooms and were not sub-
jected to control of temperature or photoperiods.
Before the start of the experiment, the animals
were trained daily for 2 weeks to sit on a restraining
chair for a period of 10 mm at the start of the train-
ing; the period was gradually extended to 2 h at the
end of the training.
Spraying of Steroids
The animals were restrained on a chair daily
between 1000 and 1030 h and sprayed intranasally
with the steroid or solvent (control) using a glass
atomizer according to the procedure described previ-
ously (Anand Kumar et al., 1977). The steroids used
were E, P or NET and the daily dose was 30 pg.
The total period of spraying was 60 days.
Histology
Testicular biopsies containing a few seminiferous
tubules were obtained from all animals after sedation
with Ketlar. The biopsies were taken I day prior to
the start of the treatment (Day 0) and the day after
the last administration of steroids (Day 61). The
tissues were processed and sectioned using routine
histological procedures and stained with hematoxylin
and eosin.
Blood Sampling and Estimations
of Testosterone and Cortisol
Blood samples were collected by venipuncture
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according to the schedule shown in Fig. I. Serum was
separated and stored at -20#{176}C until all samples from
each animal were subjected to the estimation of
testosterone by specific radioimmunoassay (RIA). The
RIA procedures used were as described in the WHO
Method Manual (1977). The antiserum used was
supplied by the WHO and had a maximum cross
reaction of 14% with dihydrotestoterone and 6.0%
with androstanediol. The sensitivity of the assay was 5
pg. The inter- and intraassay variations were 4.8-7.2%
and 4.9-8.3%, respectively.
Plasma cortisol was estimated by fluorimetric
method (Mattingly, 1962). The inter- and intraassay
variations were 3.8-6.9% and 5.2-9.3%, respectively.
Statistical Evaluation
The mean value of serum testosterone levels in
samples obtained on the day prior to the start of the
treatment period, 30 days after treatment and on the
day following the end of the 60 days of treatment
(Day 61) were compared by Cochran’s modified t test
(Snedecor and Cochran, 1967).
RESULTS
Before the start of the treatment, the testes
were well developed and were situated in the
scrotum. The testes decreased in size after 30
days of steroid administration, and the reduc-
tion in their size was more marked at the end of
60 days of treatment. In the E-treated mon-
keys, the testes were not only reduced in size
but also had retracted into the inguinal canal at
the end of 60 days of treatment.
The testes of the solvent-treated controls
remained unaffected.
Histology
Testicular histology prior to the treatment as
well as in the solvent-treated controls revealed
the occurrence of all stages of spermatogenesis
(Fig. 2a). In the E- and NET-treated monkeys,
there was a marked reduction in the diameter
of the seminiferous tubules, and the tubules
contained only spermatogonia and Sertoli cells
(Fig. 2b,c). All other stages of spermatogenesis
(spermatocytes, spermatids and spermatozoa)
were absent. In the P-treated monkeys (Fig.
2d), the reduction in the diameter of the
seminiferous tubules was not as marked as that
observed in E- or NET-treated monkeys; the
tubules, however, had fewer spermatids as
compared with controls.
Serum Testosterone Levels
The mean values of the serum testosterone
levels (Fig. 3) in blood samples obtained at 10
mm intervals (Fig. la) during the forenoon
prior to the start of the treatment varied
between animals as well as between the months
during which the experiments were carried out.
The variations were within the range of serum
testosterone levels normally encountered in
adult male rhesus monkeys in our colony
during the different months of the year (un-
published observations).
A progressive decline in the mean values of
serum testosterone levels was evident in all the
animals treated with steroids (E, P or NET),
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FIG. 1. Experimental design to show the period of intranasal spraying (dark bars) and collection of blood
samples (a, b and c).
a) Blood samples taken at intervals of 10 mm over a period of 2 h (1000-1200 h) on the day prior to the
start of the spraying, 30 days after spraying and on the day following the end of the 60 days of spraying for
estimating serum levels of testosterone.
b) Three blood samples taken weekly at intervals of 15 mm (1000-1030 h) for estimating serum levels of
testosterone. The first sample was taken just prior to the spraying and the others at 15 and 30 mm after spray-
ing.
c) Blood samples taken at 0800 h and 2000 h 4 days prior to the start of the spraying period and 2 days
after the end of spraying period for estimating levels of plasma cortisol.
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FIG. 2. Testicular histology of rhesus monkeys treated with a) solvent only, b) E, c) NET or d) P. A reduc-
tion in the diameter of the seminiferous tubules and the arrest of spermatogenesis are evident in the E- or NET-
treated animals. Progesterone treatment caused least effects on testicular histology, but note that there are
fewer spermatids in the tubules as compared with the controls. X240.
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and at the end of the treatment period the
reduction was statistically significant as com-
pared with the mean values of serum testos-
terone levels observed in blood samples ob-
tained before the start of treatment (Fig. 3).
Serum testosterone levels did not show any
In
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change in the solvent-treated controls (Fig. 3).
The pattern of serum testosterone levels
observed in the three samples taken weekly
according to the schedule described (Fig. ib)
is shown in Fig. 4. Values for one representative
animal from each treatment group are mdi-
FIG. 3. Serum levels of testosterone in rhesus monkeys treated with various steroids or solvent alone. Each
of the 3 bars in a set indicates testosterone values in samples taken from each animal before the treatment,
after 30 days of treatment and on the day following 60 days of treatment. One of the animals treated with
NET died after 40 days of treatment due to causes not related to the treatment, and studies could not be com-
pleted in this animal. Each bar represents the mean values (± SEM) of testosterone in blood samples collected at
10 mm intervals.
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FIG. 4. Serum levels of testosterone in weekly blood samples taken at 0, 15 and 30 mm from representative
animals of each treatment group.
cated. In most of the animals serum testos-
terone showed a sharp rise in samples taken 15
mm after spraying steroid or solvent alone. The
reason for this is not known. However, in all
the steroid-treated animals testosterone levels
dropped after 30 mm of spraying.
Plasma cortisol levels before, during and at
the end of treatment with steroids or solvent
showed no significant changes and these were
within the normal range of values reported for
rhesus monkeys (Michael et al., 1974).
DISCUSSION
The present studies have shown that there is
an impairment of spermatogenesis and a signifi-
cant reduction in levels of circulating serum
testosterone following intranasal administration
of E, P or NET to adult rhesus monkeys.
Animals sprayed with the solvent alone did not
show such changes. Plasma cortisol levels in all
the animals before and after the treatment were
within the normal range for this species, and
therefore, it would seem that the observed
changes were due to the treatment.
The regressive changes in testicular function
following intranasal administration of steroids
are essentially similar to those already reported
following oral or systemic administration of
estrogens or progestins (Balze et al., 1954;
Heller et al., 1958; Geller et al., 1965; McLeod,
1965; Johansson and Nygren, 1973; Frick et
a!., 1976). However, the main difference
between the previously reported studies and
ours lies in the dosages used to achieve com-
parable effects. Suppression of spermatogenesis
occurs in human subjects following daily i.m.
injections of as much as 50 mg of P, which is
‘\‘700 pg/kg BW. Synthetic progestins (Nilvar,
Nortutin and Enovid) need to be injected at a
940 ANAND KUMAR ET AL.
Anand Kumar, T. C., David, G.F.X. and Pun, V.
daily dose of “400 pg/kg BW (Heller et al.,
1958). In our studies similar effects on the
testes were observed by administering as little
as 2.72-4 pg/kg BW of the steroids by the
intranasal route.
This difference in the dosages to achieve
comparable effects may well be due to the way
in which steroids are transferred to the target
tissues by different routes. The pattern of
steroid transfer into the cerebrospinal fluid
(csf) has been shown to differ between the
intranasal route of administration and systemic
injections (Anand Kumar et al., 1978). Steroids
sprayed mntranasally reach a much higher
concentration in the csf as compared with i.m.
injections. Therefore, the concentration of
steroids in the brain, where neuroendocrine
mechanisms regulate the secretion of pituitary
gonadotropin, would also be much higher
following intranasal administration compared
with systemic injection.
It is therefore possible that regressive changes
in the testes occur when considerably lower
dosages of the steroids are administered by the
intranasal route than by the systemic routes
because the steroids reach higher concentration
in the brain when administered intranasally.
Thus the present studies have shown that
steroid administered by the intranasal route do
affect testicular function. However, a much
larger series of studies needs to be carried out
to determine the effects of such treatment on
mating behavior and to evaluate spermato-
genesis following cessation of treatment. Such
studies are under way in our laboratories.
ACKNOWLEDGMENTS
This work was supported by WHO Task Force
Project No. 77119.
REFERENCES
(1977). Ovulation in rhesus monkeys suppressed
by intranasal administration of progesterone and
norethisterone. Nature 270, 532-534.
Anand Kumar, T. C., David, G.F.X. and Pun, V.
(1979). Nasal spray contraceptives. In: Recent
Advances in Reproduction and Regulation of
Fertility. (G. P. Talwar, ed.). Elsevier, Nether-
lands. pp. 49-56.
Balze, F. A., de La Mancini, R. E., Bur, G. E. and
Irazu, J. (1954). Morphologic and histochemical
changes produced by estrogens on adult human
testes. Fertil. Steril. 5, 421-436.
Frick, J., Bartsch, G. and Marberger, H. (176). Ste-
roidal compounds (injectable and implants)
affecting spermatogenesis in men. J. Reprod.
Fert. 48 (Suppl. 24), 3 5-47.
Geller, J., Bora, R., Roberts, T., Newman, H., Lin,
A. and Silva, R. (1965). Treatment of benign
prostatic hypertrophy with hydroxyprogesterone
caproate. JAMA 193, 121-129.
Heller, C. G., Laidlaw, W. M., Harvey, H. T. and
Nelson, W. 0. (1958). Effects of progestational
compounds on the reproductive process
of human male. Ann. N.Y. Acad. Sci. 71,
649-65 5.
Johansson, E.D.B. and Nygren, K. G. (1973).
Depression of plasma testosterone levels
in men with norethindrone. Contraception,
8, 219-226.
Mattingly, D. (1962). A simple fluorimetric method
for the estimation of free 1 1-hydroxycorticoste-
roid in human plasma. J. Clin. Pathol. 15, 374-
379.
McLeod, J. (1965). Human seminal cytology follow-
ing the administration of certain antispermato-
genie compounds. In, Agents Affecting Fertility.
(C. R. Austin and J. S. Perry, eds.). J. & A.
Churchill Ltd., London. pp. 93-123.
Michael, R. P., Setchell, K.D.R. and Plant, T. M.
(1974). Diurnal changes in plasma testosterone
and studies on plasma corticosteroids in non-
anaesthetized male rhesus monkeys (Macaca
mulatta). J. Endocrinol. 63, 325-335.
Snedcor, G. W. and Cochran, W. G. (1967). Statistical
Methods. 6th Ed. Oxford and IBH Publishing
Co., New Delhi.
WHO programme for the provision of matched
assay reagents for the radioimmunoassay
of hormones in reproductive physiology.
(1977). Assay Method Manual No. HRP/77.1.
Geneva.
